Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements
- PMID: 1680287
- PMCID: PMC1683179
Missense mutations and evolutionary conservation of amino acids: evidence that many of the amino acids in factor IX function as "spacer" elements
Abstract
We report 31 point mutations in the factor IX gene and explore the relationship between the level of evolutionary conservation of an amino acid and the probability of a mutation causing hemophilia B. From our total sample of 125 hemophiliacs and from those reported by others, we identify 95 independent missense mutations, 94 of which occur at amino acids that are evolutionarily conserved in the available mammalian factor IX sequences. The likelihood of a missense mutation causing hemophilia B depends on whether the residue is also conserved in the factor IX-related proteases: factor VII, factor X, and protein C. Most of the possible missense mutations in generically conserved residues (i.e., those conserved in factor IX and in all the related proteases) should cause disease. In contrast, missense mutations in factor IX-specific residues (i.e., those conserved in human, cow, dog, and mouse factor IX but not in the related proteases) are sixfold less likely to cause disease. Missense mutations at nonconserved residues are 33-fold less likely to cause disease. At least three models are compatible with these observations. A comparison of sequence alignments from four and nine species of factor IX and an examination of the missense mutations occurring at CpG residues suggest a model in which most residues fall on opposite ends of a spectrum. In about 40% of residues, virtually any missense mutation in a minority of the residues will cause disease, while virtually no missense mutations will cause disease in most of the remaining residues. Thus, many of the residues in factor IX are spacers; that is, the main chains are presumably necessary to keep other amino acid interactions in register, but the nature of the side chain is unimportant.
Similar articles
-
Determinants of the factor IX mutational spectrum in haemophilia B: an analysis of missense mutations using a multi-domain molecular model of the activated protein.Hum Genet. 1994 Dec;94(6):594-608. doi: 10.1007/BF00206951. Hum Genet. 1994. PMID: 7989034
-
Assessing the underlying pattern of human germline mutations: lessons from the factor IX gene.FASEB J. 1992 Jul;6(10):2767-74. doi: 10.1096/fasebj.6.10.1634040. FASEB J. 1992. PMID: 1634040 Review.
-
Mutations causing hemophilia B: direct estimate of the underlying rates of spontaneous germ-line transitions, transversions, and deletions in a human gene.Am J Hum Genet. 1990 Aug;47(2):202-17. Am J Hum Genet. 1990. PMID: 2198809 Free PMC article.
-
A method to estimate effects of amino acid substitutions in blood coagulation factor IX from hemophilia B patients.Medinfo. 1995;8 Pt 2:909. Medinfo. 1995. PMID: 8591581
-
Human germline mutation in the factor IX gene.Mutat Res. 2001 Nov 1;487(1-2):1-17. doi: 10.1016/s0921-8777(01)00108-2. Mutat Res. 2001. PMID: 11595404 Review.
Cited by
-
The pattern of spontaneous germ-line mutation: relative rates of mutation at or near CpG dinucleotides in the factor IX gene.Hum Genet. 1993 Jun;91(5):496-503. doi: 10.1007/BF00217779. Hum Genet. 1993. PMID: 8314564
-
The rates of G:C-->T:A and G:C-->C:G transversions at CpG dinucleotides in the human factor IX gene.Am J Hum Genet. 1994 May;54(5):831-5. Am J Hum Genet. 1994. PMID: 8178822 Free PMC article.
-
Two Different Antibody-Dependent Enhancement (ADE) Risks for SARS-CoV-2 Antibodies.Front Immunol. 2021 Feb 24;12:640093. doi: 10.3389/fimmu.2021.640093. eCollection 2021. Front Immunol. 2021. PMID: 33717193 Free PMC article.
-
Recurrent mutations in the factor IX gene: founder effect or repeat de novo events. Investigation of the German haemophilia B population and review of de novo mutations.Hum Genet. 1993 Aug;92(1):40-8. doi: 10.1007/BF00216143. Hum Genet. 1993. PMID: 8365725
-
X-ray structure of clotting factor IXa: active site and module structure related to Xase activity and hemophilia B.Proc Natl Acad Sci U S A. 1995 Oct 10;92(21):9796-800. doi: 10.1073/pnas.92.21.9796. Proc Natl Acad Sci U S A. 1995. PMID: 7568220 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources